1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Allergy Immunotherapies Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Allergy Immunotherapies Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Allergy Immunotherapies Market Regional Analysis
6.2 Europe Allergy Immunotherapies Market Revenue 2017-2027 (US$ Million)
6.3 Europe Allergy Immunotherapies Market Forecast Analysis
7. Europe Allergy Immunotherapies Market Analysis – by Treatment
7.1 Subcutaneous Immunotherapy
- 7.1.1 Overview
- 7.1.2 Subcutaneous Immunotherapy: Europe Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Sublingual Immunotherapy
- 7.2.1 Overview
- 7.2.2 Sublingual Immunotherapy: Europe Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Europe Allergy Immunotherapies Market Analysis – by Allergy Type
8.1 Allergic Rhinitis
- 8.1.1 Overview
- 8.1.2 Allergic Rhinitis: Europe Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Asthma
- 8.2.1 Overview
- 8.2.2 Asthma: Europe Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Food Allergy
- 8.3.1 Overview
- 8.3.2 Food Allergy: Europe Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Venom Allergy
- 8.4.1 Overview
- 8.4.2 Venom Allergy: Europe Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Europe Allergy Immunotherapies Market Analysis – by Distribution Channel
9.1 Hospital Pharmacy
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacy: Europe Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Retail Pharmacy and Online Pharmacy
- 9.2.1 Overview
- 9.2.2 Retail Pharmacy and Online Pharmacy: Europe Allergy Immunotherapies Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. Europe Allergy Immunotherapies Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Allergy Immunotherapies Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 Europe Allergy Immunotherapies Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Allergy Immunotherapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 UK: Europe Allergy Immunotherapies Market Breakdown, by Treatment
- 10.2.1.1.2 UK: Europe Allergy Immunotherapies Market Breakdown, by Allergy Type
- 10.2.1.1.3 UK: Europe Allergy Immunotherapies Market Breakdown, by Distribution Channel
- 10.2.1.2 Germany:
Europe Allergy Immunotherapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Germany: Europe Allergy Immunotherapies Market Breakdown, by Treatment
- 10.2.1.2.2 Germany: Europe Allergy Immunotherapies Market Breakdown, by Allergy Type
- 10.2.1.2.3 Germany: Europe Allergy Immunotherapies Market Breakdown, by Distribution Channel
- 10.2.1.3 France:
Europe Allergy Immunotherapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 France: Europe Allergy Immunotherapies Market Breakdown, by Treatment
- 10.2.1.3.2 France: Europe Allergy Immunotherapies Market Breakdown, by Allergy Type
- 10.2.1.3.3 France: Europe Allergy Immunotherapies Market Breakdown, by Distribution Channel
- 10.2.1.4 Russia:
Europe Allergy Immunotherapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.4.1 Russia: Europe Allergy Immunotherapies Market Breakdown, by Treatment
- 10.2.1.4.2 Russia: Europe Allergy Immunotherapies Market Breakdown, by Allergy Type
- 10.2.1.4.3 Russia: Europe Allergy Immunotherapies Market Breakdown, by Distribution Channel
- 10.2.1.5 Italy:
Europe Allergy Immunotherapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.5.1 Italy: Europe Allergy Immunotherapies Market Breakdown, by Treatment
- 10.2.1.5.2 Italy: Europe Allergy Immunotherapies Market Breakdown, by Allergy Type
- 10.2.1.5.3 Italy: Europe Allergy Immunotherapies Market Breakdown, by Distribution Channel
- 10.2.1.6 Rest of Europe:
Europe Allergy Immunotherapies Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Allergy Immunotherapies Market Breakdown, by Treatment
- 10.2.1.6.2 Rest of Europe: Europe Allergy Immunotherapies Market Breakdown, by Allergy Type
- 10.2.1.6.3 Rest of Europe: Europe Allergy Immunotherapies Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 HAL Allergy B.V.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 ALK Abello A/S
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Stallergenes Greer
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Anergis
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Circassia
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations